Start Date
March 31, 2016
Primary Completion Date
April 30, 2019
Study Completion Date
May 31, 2019
Trastuzumab emtansine
HER2-targeted antibody drug conjugate of trastuzumab and DM1
Houston Methodist Hospital, Houston
Collaborators (1)
Genentech, Inc.
INDUSTRY
The Methodist Hospital Research Institute
OTHER
Jenny C. Chang, MD
OTHER